How a Tiny Capsule Can Treat Age-Related Macular Degeneration

Katelyn Swindle-Reilly, Ph.D.
The Ohio State University

Assistant Professor, Biomedical Engineering, Chemical and Biomolecular Engineering, and Ophthalmology and Visual Sciences, Department of Biomedical Engineering

Dr. Swindle-Reilly is developing local ocular drug delivery technologies for patients with age-related macular degeneration, the third leading cause of blindness, which currently has no cure. The technology, in the form of biodegradable injectable implants, will reduce the frequency of patient treatment and improve visual outcomes.

Bio: https://bme.osu.edu/people/reilly.198
Lab: https://bme.osu.edu/swindle-reilly-la...
University: https://osu.edu

View more PITCH X talks on the PITCH X Ohio YouTube Channel.

About InnovateOhio, IP Promise and PITCH X
Born from the knowledge that we have world-changing discoveries every year that originate in universities but need help moving from lab to market, Ohio’s I.P. Promise was launched by Lt. Governor Jon Husted as an extension of InnovateOhio in fall 2019. A total of 16 Ohio universities agreed to work together to make technology commercialization faster, easier and more impactful.

PITCH X: From Lab to Market is a series of talks from university entrepreneurs discussing technologies ready to make a difference in the world through commercialization. By raising awareness for breakthrough technologies developed right here in Ohio, PITCH X is helping connect university research with private sector investment as Ohio grows its innovation economy.

For more information on PITCH X and the nomination process, visit innovateohio.gov